120
Participants
Start Date
September 21, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
October 31, 2026
ChAdOx1-HBV
Chimpanzee Adenovirus Oxford 1-vectored Hepatitis B virus immunotherapeutic
MVA-HBV
Modified Vaccinia Ankara-vectored Hepatitis B virus immunotherapeutic
Nivolumab
Human immunoglobulin G4 monoclonal antibody
Linkou Chang Gung Memorial Hospital, Taoyuan
National Cheng Kung University Hospital, Tainan City
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Chulabhorn Hospital, Bangkok
King Chulalongkorn Memorial Hospital, Bangkok
Bamrasnaradura Infectious Diseases Institute, Nonthaburi
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai
Chia-Yi Christian Hospital, Chiayi City
China Medical University Hospital, Taichung
Prince Of Wales Hospital, Hong Kong
Queen Mary Hospital, Hong Kong
Dalin Tzu Chi Hospital, Chiayi City
Chang Gung Memorial Hospital Kaohsiung, Kaohsiung City
National Taiwan University Hospital, Taipei
HIV Netherlands-Australia-Thailand Research Collaboration, Bangkok
Hospital For Tropical Diseases, Bangkok
Research Institute For Health Sciences, Chiang Mai
Srinagarind Hospital, Khon Kaen
Lead Sponsor
Barinthus Biotherapeutics
INDUSTRY